Viking Therapeutics has seen a significant drop, despite positive news and promising GLP-1 drug developments. Find out why ...

The current regulatory environment in the U.S. tolerates overly large PBMs that engage in anticompetitive practices to accumulate excessive profits. Without strong competitors, dominant PBMs are free ...

Groundbreaking weight-loss drugs like Ozempic and Wegovy have understandably generated a lot of excitement, bringing hope to ...

In Michigan, the state’s largest insurer has tightened restrictions around medications like Wegovy. Patients are panicking.

In an effort to reduce fuel costs, American Airlines was the first US carrier to introduce checked baggage fees, at US$15 in ...

Biden officials recently proposed allowing Medicare to start covering GLP-1 medications to treat obesity. It's unclear ...

Can the new strategy achieve the great shift Reed has called for, or is the process doomed to failure from the start?